COSTA MESA, Calif., Feb. 10, 2011 /PRNewswire/ -- Renaissance Surgical Arts at Newport Harbor announced today that it is the first outpatient surgery center in the Western United States to offer intraoperative radiotherapy (IORT) using the INTRABEAM® System – the only device used in the TARGIT-A multicenter human clinical trial that demonstrated IORT to be as effective as traditional radiation for certain women with early breast cancer.
IORT has the potential to replace as many as six and a half weeks of routine radiation therapy with 20-30 minutes of targeted radiation administered during surgery directly to the tumor site after lumpectomy.
"IORT is a game-changer for women facing breast cancer – I like to call it one and done," said Dr. Alice Police, breast surgeon at Renaissance and co-founder of Pacific Breast Care in Newport Beach, Calif. "For some women in the earlier stages of breast cancer, IORT makes it possible for them to have one surgery consisting of lumpectomy and single-dose radiation therapy and then go on with their life having completed their breast cancer treatment."
Unlike whole breast radiation treatment, which is administered five times per week for as many as six and a half weeks, IORT provides patients with a targeted single-dose radiation treatment delivered intraoperatively after removal of the tumor. Radiation is applied for 20-30 minutes, exposing the affected tissue in the tumor bed from the inside.
"Dr. Police's passion for IORT as a revolutionary development in treating early breast cancers aligned with our mission to deliver the best surgical technologies available to patients in a comfortable and private outpatient environment," said Bruce Wallace, CEO and Administrator for Renaissance Surgical Arts at Newport Harbor. "We looked at IORT device manufacturers and it was clear that the INTRABEAM System was the only responsible choice given its exclusive use in the